International Journal of Cancer · 2011 · 50 citations · 30 references
MedicineMolecular BiologyOncologyGene ExpressionNeoplasiaTumor ProgressionCancer BiomarkersCancer ProgressionCancer TranscriptomicsLung CancerMalignant NeoplasmsMolecular Tumor ProfilingLung AdenocarcinomaLung CarcinogenesisLymph Node Metastasis PrognosisMalignant ProgressionMicroarray AnalysisPrognostic Molecular Stratification
Adenocarcinoma in situ (AIS) of the lung has an extremely favorable prognosis, with a 5-year survival rate of 100%. However, early invasive adenocarcinoma (EIA) often has a fatal outcome. In this study, we compared the expression profiles of AIS with those of EIA showing lymph node metastasis or a fatal outcome, and screened the differentially expressed genes by cDNA microarray. From the genes selected, we focused on Stratifin (SFN, 14-3-3 σ), which showed significantly higher expression in EIA than in AIS. Immunohistochemistry for SFN revealed that more than 95% of EIAs were immunopositive for SFN, in comparison to only 13% of AISs (p <0.05). Interestingly, positivity was detected not only in the invasive region but also in the in situ spreading component of EIA. Functionally, SFN facilitates the cell proliferation capacity of lung adenocarcinoma. These results indicate that SFN overexpression is a universal abnormality during the stepwise progression from in situ to invasive adenocarcinoma of the lung.
30
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2009 · 9.7K citations · Full text
Is a p53-Regulated Inhibitor of G2/M Progression
Heiko Hermeking, Christoph Lengauer, Kornélia Polyák et al. · Molecular Cell · 1997 · 1.2K citations · Full text
Small adenocarcinoma of the lung. Histologic characteristics and prognosis
Masayuki Noguchi, Masanori Kawasaki, Yoshihiro Matsuno et al. · Cancer · 1995 · 1.2K citations
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Timothy A. Chan, Heiko Hermeking, Christoph Lengauer et al. · Nature · 1999 · 890 citations